{"id":50684,"date":"2025-07-18T07:38:28","date_gmt":"2025-07-18T11:38:28","guid":{"rendered":"https:\/\/thestockmarketwatch.com\/stock-market-news\/strong-earnings-from-american-express-and-charles-schwab-bristol-myers-drug-trial-misses-endpoint\/50684\/"},"modified":"2025-07-18T07:38:28","modified_gmt":"2025-07-18T11:38:28","slug":"strong-earnings-from-american-express-and-charles-schwab-bristol-myers-drug-trial-misses-endpoint","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/strong-earnings-from-american-express-and-charles-schwab-bristol-myers-drug-trial-misses-endpoint\/50684\/","title":{"rendered":"Strong Earnings from American Express and Charles Schwab, Bristol Myers&#8217; Drug Trial Misses Endpoint"},"content":{"rendered":"<p><strong>Key Takeaways:<\/strong><\/p>\n<ul>\n<li><strong>American Express (<a href=\"\/stock\/AXP\">AXP<\/a>)<\/strong> reported robust Q2 2025 results, significantly surpassing analyst expectations for both revenue and EPS, driven by strong billed business growth and reaffirmed optimistic full-year guidance.<\/li>\n<li><strong>Charles Schwab (<a href=\"\/stock\/SCHW\">SCHW<\/a>)<\/strong> also exceeded Q2 2025 estimates for adjusted EPS, net revenue, and daily average trades, though bank deposits fell short of forecasts.<\/li>\n<li><strong>Bristol Myers Squibb (<a href=\"\/stock\/BMY\">BMY<\/a>)<\/strong> announced that its Phase 3 INDEPENDENCE trial for Reblozyl did not meet its primary endpoint, a setback for the drug in myelofibrosis-associated anemia.<\/li>\n<li><strong>Deutsche Bank<\/strong> raised its price target for <strong>Microsoft (<a href=\"\/stock\/MSFT\">MSFT<\/a>)<\/strong> to <strong>$550<\/strong> from <strong>$500<\/strong>, maintaining a Buy rating, signaling increased confidence in the tech giant.<\/li>\n<\/ul>\n<ul>\n<li>\n<p><strong>American Express (<a href=\"\/stock\/AXP\">AXP<\/a>)<\/strong> delivered a strong performance in the second quarter of 2025, with revenue reaching <strong>$17.86 billion<\/strong>, exceeding the estimated <strong>$17.71 billion<\/strong>. The company&#39;s EPS came in at <strong>$4.08<\/strong>, significantly higher than the <strong>$3.87<\/strong> consensus estimate. <em>This robust growth was further supported by billed business climbing to <strong>$416.38 billion<\/strong>, surpassing the <strong>$412.79 billion<\/strong> estimate<\/em>. American Express also reaffirmed its full-year EPS guidance of <strong>$15<\/strong> to <strong>$15.50<\/strong> and revenue growth of <strong>+8%<\/strong> to <strong>+10%<\/strong>, indicating continued confidence in its financial outlook.<\/p>\n<\/li>\n<li>\n<p><strong>Charles Schwab (<a href=\"\/stock\/SCHW\">SCHW<\/a>)<\/strong> reported a mixed but generally positive second quarter for 2025. The financial services firm posted adjusted EPS of <strong>$1.14<\/strong>, beating the estimated <strong>$1.09<\/strong>, and net revenue of <strong>$5.85 billion<\/strong>, above the <strong>$5.72 billion<\/strong> expectation. Daily average trades also exceeded forecasts at <strong>7.57 million<\/strong> compared to an estimated <strong>7.51 million<\/strong>. However, bank deposits were a notable miss, coming in at <strong>$233.1 billion<\/strong> against an estimated <strong>$238.22 billion<\/strong>. <em>Despite the deposit shortfall, the overall earnings beat suggests resilience in its core brokerage and asset management businesses<\/em>.<\/p>\n<\/li>\n<li>\n<p>In pharmaceutical news, <strong>Bristol Myers Squibb (<a href=\"\/stock\/BMY\">BMY<\/a>)<\/strong> faced a setback as its Phase 3 INDEPENDENCE trial for Reblozyl (luspatercept-aamt) in adult patients with myelofibrosis-associated anemia did not meet its primary endpoint. <em>This outcome could impact the drug&#39;s expansion into new indications, despite previous successes in other blood disorders<\/em>.<\/p>\n<\/li>\n<li>\n<p><strong>Microsoft (<a href=\"\/stock\/MSFT\">MSFT<\/a>)<\/strong> received a positive analyst note from Deutsche Bank, which increased its price target for the tech giant to <strong>$550<\/strong> from <strong>$500<\/strong>. Deutsche Bank maintained its Buy rating on the shares, <em>reflecting continued optimism regarding Microsoft&#39;s growth trajectory and market position<\/em>.<\/p>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways: American Express (AXP) reported robust Q2 2025 results, significantly surpassing analyst expectations for both revenue and EPS, driven [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[6007,33,6008,215,6009,808,1807,2146,5043,5587,5657,5775],"class_list":["post-50684","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-american-express","tag-msft","tag-charles-schwab","tag-bmy","tag-bristol-myers-squibb","tag-axp","tag-earnings","tag-schw","tag-technology","tag-financial-services","tag-microsoft","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/50684","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=50684"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/50684\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=50684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=50684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=50684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}